Corteva, Inc. (NYSE:CTVA) Shares Sold by FineMark National Bank & Trust

FineMark National Bank & Trust cut its holdings in Corteva, Inc. (NYSE:CTVAGet Rating) by 11.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,233 shares of the company’s stock after selling 1,093 shares during the quarter. FineMark National Bank & Trust’s holdings in Corteva were worth $389,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in CTVA. Morgan Stanley lifted its position in shares of Corteva by 23.2% in the third quarter. Morgan Stanley now owns 5,711,897 shares of the company’s stock valued at $240,356,000 after acquiring an additional 1,075,445 shares in the last quarter. Invesco Ltd. boosted its stake in Corteva by 7.1% during the 3rd quarter. Invesco Ltd. now owns 15,314,085 shares of the company’s stock worth $644,418,000 after purchasing an additional 1,013,245 shares during the last quarter. Lazard Asset Management LLC grew its holdings in shares of Corteva by 553.0% during the fourth quarter. Lazard Asset Management LLC now owns 1,044,481 shares of the company’s stock worth $49,382,000 after buying an additional 884,537 shares in the last quarter. UBS Group AG grew its stake in Corteva by 52.1% during the 3rd quarter. UBS Group AG now owns 2,044,208 shares of the company’s stock valued at $86,022,000 after acquiring an additional 700,206 shares in the last quarter. Finally, Renaissance Technologies LLC raised its holdings in Corteva by 167.6% in the 3rd quarter. Renaissance Technologies LLC now owns 1,095,900 shares of the company’s stock valued at $46,115,000 after acquiring an additional 686,300 shares during the last quarter. 79.46% of the stock is owned by institutional investors and hedge funds.

In other Corteva news, Director Klaus A. Engel sold 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 15th. The shares were sold at an average price of $52.76, for a total transaction of $158,280.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.08% of the stock is currently owned by company insiders.

Several research firms recently commented on CTVA. Vertical Research cut Corteva from a “buy” rating to a “hold” rating and set a $58.00 price target for the company. in a report on Thursday, April 14th. Loop Capital raised Corteva from a “hold” rating to a “buy” rating and set a $69.00 target price for the company in a research note on Thursday, April 14th. JPMorgan Chase & Co. cut shares of Corteva from an “overweight” rating to a “neutral” rating and set a $58.00 price target on the stock. in a research report on Friday, May 6th. They noted that the move was a valuation call. KeyCorp raised their price objective on shares of Corteva from $58.00 to $63.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 5th. Finally, Argus increased their price target on shares of Corteva from $61.00 to $69.00 and gave the company a “buy” rating in a research note on Monday. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $60.21.

NYSE CTVA opened at $62.09 on Wednesday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.64 and a quick ratio of 1.13. The company has a market cap of $44.93 billion, a P/E ratio of 26.42, a P/E/G ratio of 1.74 and a beta of 0.65. The stock has a 50-day moving average of $58.03 and a two-hundred day moving average of $51.88. Corteva, Inc. has a 1-year low of $40.60 and a 1-year high of $62.20.

Corteva (NYSE:CTVAGet Rating) last announced its quarterly earnings data on Wednesday, May 4th. The company reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.81 by $0.16. The firm had revenue of $4.60 billion during the quarter, compared to analysts’ expectations of $4.47 billion. Corteva had a net margin of 10.72% and a return on equity of 6.70%. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.79 earnings per share. On average, analysts anticipate that Corteva, Inc. will post 2.53 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 15th. Stockholders of record on Friday, May 13th will be given a dividend of $0.14 per share. The ex-dividend date is Thursday, May 12th. This represents a $0.56 annualized dividend and a dividend yield of 0.90%. Corteva’s dividend payout ratio is currently 23.83%.

About Corteva (Get Rating)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Recommended Stories

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.